Latest News

Date Title Topic
15 Apr 2016 ELCC 2016 News: Novel Durvalumab plus Gefitinitib Shows Promise in EGFR Mutated NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Comprehensive Molecular Profiling Shows Disparity Between Primary NSCLC Tumours and Metastases Pathology/Molecular biology - Lung and other thoracic tumours
15 Apr 2016 ELCC 2016 Press Release: Studies Confirm Benefit of Plasma Genotyping to Predict Treatment Benefit in Patients with Non-Small-Cell Lung Cancer Lung and other thoracic tumours
15 Apr 2016 ELCC 2016 Press Release: Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy Lung and other thoracic tumours - Anticancer agents & Biologic therapy
14 Apr 2016 Press Statement: ESMO Welcomes Final Version of European Data Protection Regulation Bioethics, legal and economic issues
14 Apr 2016 ELCC 2016 News: Elderly Patients with Malignant Pleural Mesothelioma Should Not Be Excluded from Extended Pleurectomy Decortication Lung and other thoracic tumours
14 Apr 2016 ELCC 2016 News: Possibility of Overtreatment Linked to Clinically-Diagnosed Early-Stage Lung Cancer Lung and other thoracic tumours
14 Apr 2016 ELCC 2016 Press Release: Immunotherapy With Live Bacterium Improves Response Rate in Malignant Pleural Mesothelioma Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
14 Apr 2016 ELCC 2016 Press Release: Osimertinib Given as First-line Treatment May Alter Biology of EGFR-Mutated Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
Abstracts
11 Apr 2016 ELCC 2016 Press Release: Heine H. Hansen Award Goes to Suresh Senan
08 Apr 2016 FDA Allows Marketing of First-of-Kind Tissue Containment System for Use With Certain Laparoscopic Power Morcellators in Select Patients
07 Apr 2016 ESMO Preceptorship on Immuno-Oncology 2016: Siena
07 Apr 2016 EMA Recommends Granting a Marketing Authorisation for Generic Palonosetron Palliative and supportive care
Programme